Indivior Pharmaceuticals (INDV) Goodwill & Intangibles (2021 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Goodwill & Intangibles of $2.0 million for Q1 2026, down 71.43% year-over-year from $7.0 million in Q1 2025, and little changed quarter-over-quarter from $2.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Goodwill & Intangibles (2021 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Goodwill & Intangibles history runs 6 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 71.43% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (down 71.43% YoY), while the FY2025 annual figure was $2.0 million, down 66.67% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $2.0 million, roughly flat from $2.0 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $70.0 million in Q4 2022, with the low at $2.0 million in Q1 2024.
- The 5-year median for Goodwill & Intangibles is $6.0 million (2024), against an average of $12.3 million.
- The sharpest annual moves came in 2023 and 2025: Goodwill & Intangibles plunged 81.43% in 2023, then soared 250.0% in 2025.
- Indivior Pharmaceuticals' Goodwill & Intangibles stood at $70.0 million in 2022, then slumped by 81.43% to $13.0 million in 2023, then tumbled by 53.85% to $6.0 million in 2024, then slumped by 66.67% to $2.0 million in 2025, then changed by 0.0% to $2.0 million in 2026.
- Business Quant data shows INDV's Goodwill & Intangibles at $2.0 million in Q1 2026, $2.0 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Indivior Pharmaceuticals | 4.57 Bn | 4.35 Bn | 294.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.00 Mn |
| Mar 31, 2026 | 2.00 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 7.00 Mn |
| Mar 31, 2025 | 7.00 Mn |
| Dec 31, 2024 | 6.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | 13.00 Mn |
| Dec 31, 2022 | 70.00 Mn |
| Dec 31, 2021 | 82.00 Mn |